F-star gets down to the wire with $161M sale to Chi­nese buy­er as na­tion­al se­cu­ri­ty con­cerns linger

With the clock tick­ing on F-star Ther­a­peu­tics’ takeover by a Chi­nese buy­er, the com­pa­nies are still scram­bling to re­move a hold on the deal from the US gov­ern­ment’s Com­mit­tee on For­eign In­vest­ment in the Unit­ed States.

F-star and in­voX Phar­ma said they are “ac­tive­ly ne­go­ti­at­ing” with CFIUS “about the terms of a mit­i­ga­tion agree­ment to ad­dress CFIUS’s con­cerns re­gard­ing po­ten­tial na­tion­al se­cu­ri­ty risks posed by the trans­ac­tion.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER